
The Faculty Resident Research Grants consist of $2,000 awards per research proposal, part of which may be utilized for travel to scientific meetings to present research results. The request for applications (RFA) is announced in the spring and the grant applications are due by the end of each academic year. After a grant review process and selection of the proposals by a faculty committee, the funding will be awarded. The funding is available to the trainee until their residency ends.
The Stead Resident Research Grant applications also consist of $2,000 awards per research proposal. Applications open in the fall of each academic year, allowing a second opportunity for residents to apply for funding. Stead Resident Research grants are funded by the Stead Scholarship Committee. The purpose of this grant is to provide funding for Internal Medicine Residents to develop their skills in clinical or laboratory-based research, to carry out research projects, to present their research findings at scientific meetings and to publish their work. This program is designed to provide residents with an opportunity to cover expenses for their research or quality improvement projects. These expenses may include (but are not limited to) IRB costs; laboratory reagents; statistical support; data collection and analysis; travel funds to present research at meetings; publication costs; and poster preparation costs.
The Residency Program provides travel funding for residents to attend and present their research abstracts and papers as posters or oral presentations at state, regional and national medical society or scientific meetings.
For more information about research funding opportunities, please contact Dr. Nia S. Mitchell, nia.s.mitchell@duke.edu
Faculty-Resident Research Grant Recipients
2024
Recipient | Mentor | Project |
---|---|---|
Hiwot Abate, MD | Kara Wegermann, MD | HBIG to Prevent HBV Recurrence in HBsAg Positive Liver Transplant Recipients |
Clare Anderson, MD | Chenyu Lin, MD | Tolerability and Outcomes of Oral Targeted Inhibitors for Chronic Lymphocytic Leukemia in Patients with Severe Renal Dysfunction |
James Davis, MD | Gerald S. Bloomfield, MD, MPH | Cardiac Testing Patterns in People Living With HIV |
Averie Dickinson, MD, MB | Kara Wegermann, MD | Impact of Class II and III Obesity on Liver Transplant Qualification and Outcomes |
Elisabeth Fassas, MD, M.Sc | Joanna Cavalier, MD | Impacts of Virtual Care Center on telehealth performance |
Reeti Gulati, MD | Amreen Dinani, MD | Real World Data Assessing the Impact of Glucagon-like Peptide-1 Receptor Agonists in Metabolic Dysfunction-Associated Steatotic Liver Disease |
Ashley Jowell, MD | Cynthia A. Moylan, MD | Exploring the Impact of Social and Environmental Vulnerabilities on Liver Disease in the South: A study of the STRIVE (Southern Liver Health Study) Cohort |
Kate Lee, MD, MS | David A. Leiman, MD | Cost Effectiveness Analysis for the Medical Treatment of Moderate and Severe Erosive Esophagitis |
Valeria Maldonado Grijalva, MD | Matthew Labriola, MD | A Retrospective Trial of Lutetium-177-PSMA-617 in Black and White Males With Metastatic Castrate-Resistant Prostate Cance |
Alison Smith, MD, M.Sc | Jason Stout, MD, MHS | Assessing Mortality and End-of-Life Care Associated with Infectious Disease Consultation: A 10-Year Retrospective Analysis |
Auston Stiefer, MD | Aparna Swaminathan, MD, MHS | Inhaled inequities: evaluating disparities among interstitial lung disease outcomes based on social and environmental factors |
Karen Young, MD | Carla Brady, MD | Solid Organ Transplant and Contraception Counseling at Duke University Hospitals |
2023
Recipient | Mentor | Project |
---|---|---|
Peter Albares, MD | Kara Wegermann, MD and Alyson Johnson, MD | Endoscopic management of enterocutaneous fistulas, a systematic review. & Endoscopic management of enterocutaneous fistulas, a quaternary care center experience. |
Clare Anderson, MD | Jie Wang MD, MS | Clinical Significance of Positive T-Cell Clonality Testing |
Benjamin Berger, MD | Elias Pratt, MD | Anticoagulation Targets in VV ECMO Patients with COVID-19 ARDS |
Mark Brahier, MD, MBA | Jonathan P. Piccini, MD, MHS | Repeat catheter ablation for atrial fibrillation: a study of procedural techniques, recurrence mechanisms, safety, and outcomes |
Melissa Cutshaw, MD, MPH | Nwora Lance Okeke, MD | Determinants associated with weight gain among persons with HIV who switch to integrase strand transfer inhibitors (INSTI) |
Sanjay Gadi, MD | Jeremy Brown, MD, MSc | Development of a Scoring System for the Evaluation & Comparison of Computer-Aided Detection Programs in Colonoscopy Using a Modified Delphi Approach |
Alexander Gunn, MD, MS | Robert Mentz, MD | Association of sacubitril-valsartan versus valsartan with healthcare utilization following worsening heart failure in patients with EF>40% |
Madeleine Hamilton, MD | Craig Rackley, MD | Predictors of Survival in Lung Transplant Patients Who Require Venovenous Extracorporeal Membrane Oxygenation in the Post- Transplant Period |
Jacquelyn Kercheval, MD | Craig Rackley, MD | Risk of Healthcare-associated Infections for Patients Supported with VV-ECMO for COVID-19 ARDS vs. ARDS from Other Causes |
Elizabeth Kobe, MD, MHS | Nishant Shah, MD | Cardiovascular Disease in People Living with HIV: Disparities in Risk Factor Optimization and Outcomes |
Kate Lee, MD, MS | Anthony Galanos, MD | The Role of Artificial Intelligence in Medical Creative Writing: Comparative Analysis of Medical Poems by Physician and GPT-4 |
Evan Murray, MD | Robert Mentz, MD | Effects of Sacubitril/Valsartan or Valsartan in De novo vs. Chronic HFpEF and HFmrEF: The PARAGLIDE-HF Trial |
Bret Pinsker, MD | Richard Krasuski, MD | Cardiac MRI Predictors of Atrial Arrhythmia Ablation Outcomes in Repaired Tetralogy of Fallot |
Shelief Robbins-Juarez, MD | Jonathan P. Piccini, MD, MHS | A Systematic Review with Meta-Analysis: Botulinum Toxin Type A for Prevention of Post-Operative Atrial Fibrillation after Cardiac Surgery |
Bari Rosenberg, MD | Thomas LeBlanc, MD, MA | Do Adult Patients with Acute Lymphoblastic Leukemia (ALL) who Receive Asparaginase as Part of Their Chemotherapy Regimen Have Improved Five-Year Overall Survival Compared to Adults with ALL Who Do Not Receive asparaginase? |
Nivita Sharma, MD | Cecelia Zhang, MD | Evaluation of Factors Affecting Deployment of Biologic Therapy in the Management of Inpatient Acute Severe Ulcerative Colitis at Duke Regional Hospital |
Karen Young, MD | Stephanie Garbarino, MD | Alcohol relapse after liver transplantation: risk factors, outcomes, and a comparison of risk stratification models |
2022
Recipient | Mentor | Project |
---|---|---|
John Barber, MD PGY 2 | Garnett Kelsoe, MD | Investigation of the role of TLR pathway mediators in AID-mediated central B-cell tolerance |
Emory Buck, MD PGY 3 | John David Ike, MD | Visual Arts Curriculum to Mitigate Internal Medicine Residents Burnout and Enhance Empathy and Tolerance for Ambiguity |
Joanna Cavalier, MD PGY 4 | Michel Khouri, MD | Racial Differences in Phenotypes and Outcomes of Cardiac Amyloid |
Michelle Ferreira, MD PGY 3 | Brent Hanks, MD | Characterizing steroid-refractory immunotherapy toxicities and effect of second-line immunosuppression on survival |
Jordan Infield, MD PGY 3 | Michael Harrison, MD | Assessing Malnutrition and the Impact of the Dietician Input in Patients with Chronic Pancreatitis |
Jacquelyn Kercheval, MD PGY 2 | Rajesh V. Swaminathan, MD | Acute Myocardial Infarction related Cardiogenic Shock Survivorship: A Pilot Study in Quality of Life |
Jacob Pierce, MD, MPH PGY 2 | Stephen J. Greene, MD | Quality of Care and Clinical Outcomes in Patients Hospitalized with Heart Failure in Rural and Urban Hospitals: Insights from Get With The Guidelines – Heart Failure |
Sukrit Jain, MD PGY 3 | Darsh Kothari, MD | Assessing Malnutrition and the Impact of the Dietician Input in Patients with Chronic Pancreatitis |
Anand Shah, MD, MBA PGY 3 | Robert J Mentz, MD | Hospital Virtual Heart Failure Consultation for Goal-directed Medical Therapy Optimization |